Magnetic materials have been used with grain sizes down to the
nanoscale for longer than any other type of material. This is because of a fundamental change in the magnetic
structure of ferro- and ferrimagnetic materials when grain sizes are reduced.
In these circumstances, the normal macroscopic domain structure transforms into a single domain state
at a critical size which typically lies below 100 nm. Once this
transformation occurs the mechanism of magnetisation reversal can only be
via the rotation of the magnetisation vector from one magnetic easy axis to
another via a magnetically hard direction. This change of reversal
mechanism has led to a new class of magnetic materials whose properties and
the basic underlying physical mechanism governing them were defined in
a seminal work first published by E C Stoner and E P Wolhfarth in 1949.
As a consequence of this rotation mechanism, magnetic nanoparticles exist
having coercivities which are highly controllable and lie between soft
materials and normal permanent magnet materials. This ability to control
coercivity in such particles has led to a number of significant
technological advances, particularly in the field of information storage.
The high value of information storage technology has meant that since the
1950s an enormous research and development effort has gone into techniques
for the preparation of magnetic particles and thin films having well
defined properties. Hence, certainly since the 1960s, a wide range of
techniques to produce both metallic and oxide magnetic nanoparticles with
sizes ranging from 4-100 nm has been developed.
The availability of this wide range of materials led to speculation from
the 1960s onwards that they may have applications in biology and medicine.
The fact that a magnetic field gradient can be used to either remotely
position or selectively filter biological materials leads to a number of
obvious applications. These applications fall broadly into two categories:
those involving the use in-vivo and those involving the use of magnetic
particles in-vitro. Obviously for safety reasons the development of in-vitro applications are more accessible. However, and somewhat ironically,
the one application currently used on a significant scale involves the use
of magnetic particles to produce a distortion in the magnetic field at a
given site under examination via magnetic resonance imaging (MRI). The
presence of the particles at a given site can alter the contrast of certain
types of cells by several orders of magnitude, making visible objects that
were hitherto difficult to image.
With the increasing sophistication of pharmaceuticals, the dramatic
development of cell manipulation and even DNA sequencing, the possibility of
using magnetic nanoparticles to improve the effectiveness of such
technologies is obviously appealing. Hence there are proposals for drug
delivery systems, particularly for anti-inflammatory agents and also for
the use of magnetic separation technologies for rapid DNA sequencing.
A further and somewhat surprising application of magnetic nanoparticles
lies in the production of controlled heating effects. Each cycle of a
hysteresis loop of any magnetic material involves an energy loss
proportional to the area of the loop. Hence if magnetic nanoparticles
having the required coercivity are remotely positioned at a given site in
the body, perhaps the site of a malignancy, then the application of an
alternating magnetic field can be used to selectively warm a given area.
It has been proposed that this simple physical effect could be used both
to destroy cells directly or to induce a modest increase in temperature so
as to increase the efficacy of either chemotherapy or radiotherapy.
Clearly this area of potential technology is highly novel and offers many
exciting possibilities for future developments. The area is relatively
young and highly multidisciplinary, requiring a range of scientific
knowledge from inorganic chemistry involved in the preparation of the
nanoparticles, through biochemistry and medical science to allow for their
functionalisation, and of course the basic physics of how the properties of
the magnetic particles can best be brought to bear. In consequence it is
not possible for a single author to be able to produce an overview of such
a wide range of disciplines in a single paper. Therefore, in this issue
of Journal of Physics D: Applied Physics we have commissioned three separate reviews
from leading groups in Western Europe covering in some detail the
preparation of magnetic nanoparticles, their functionalisation with
appropriate biomolecules for different applications and a review of the
fundamental underlying physics behind the technology. We hope that this
somewhat unusual combination of review articles in an applied physics
journal will be of benefit to all those in the scientific community with
interests in this area.
We are most grateful to all the authors of the
three papers for their contribution to this issue of Journal of Physics D: Applied Physics
and in particular for their willingness to coordinate their submissions so as to
enable this cluster of review articles to appear in a single issue.